AT380883B - Verfahren zur herstellung von neuen 1-oxo-1h -thiazolo(3,2-a)pyrimidin-2-carboxamiden - Google Patents

Verfahren zur herstellung von neuen 1-oxo-1h -thiazolo(3,2-a)pyrimidin-2-carboxamiden

Info

Publication number
AT380883B
AT380883B AT0570780A AT570780A AT380883B AT 380883 B AT380883 B AT 380883B AT 0570780 A AT0570780 A AT 0570780A AT 570780 A AT570780 A AT 570780A AT 380883 B AT380883 B AT 380883B
Authority
AT
Austria
Prior art keywords
thiazolo
carboxamides
pyrimidine
oxo
producing new
Prior art date
Application number
AT0570780A
Other languages
German (de)
English (en)
Other versions
ATA570780A (de
Inventor
Saul Bernard Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to AT80084A priority Critical patent/ATA80084A/de
Publication of ATA570780A publication Critical patent/ATA570780A/de
Application granted granted Critical
Publication of AT380883B publication Critical patent/AT380883B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT0570780A 1979-11-23 1980-11-21 Verfahren zur herstellung von neuen 1-oxo-1h -thiazolo(3,2-a)pyrimidin-2-carboxamiden AT380883B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT80084A ATA80084A (de) 1979-11-23 1984-03-09 Verfahren zur herstellung von 1-oxo-1h-thiazolo(3,2-a)pyrimidin-2-carbonsaeure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23

Publications (2)

Publication Number Publication Date
ATA570780A ATA570780A (de) 1985-12-15
AT380883B true AT380883B (de) 1986-07-25

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0570780A AT380883B (de) 1979-11-23 1980-11-21 Verfahren zur herstellung von neuen 1-oxo-1h -thiazolo(3,2-a)pyrimidin-2-carboxamiden

Country Status (35)

Country Link
JP (1) JPS5687586A (da)
KR (1) KR830004322A (da)
AR (2) AR228859A1 (da)
AT (1) AT380883B (da)
AU (1) AU520995B2 (da)
BE (1) BE886319A (da)
CA (1) CA1143731A (da)
CH (1) CH649299A5 (da)
CS (1) CS241476B2 (da)
DD (1) DD154608A5 (da)
DE (2) DE3043979C2 (da)
DK (1) DK151811C (da)
EG (1) EG14929A (da)
ES (1) ES8203363A1 (da)
FI (1) FI67706C (da)
FR (1) FR2470132A1 (da)
GB (1) GB2063862B (da)
GR (1) GR72132B (da)
GT (1) GT198066458A (da)
HU (1) HU179091B (da)
IE (1) IE50404B1 (da)
IL (1) IL61535A (da)
IN (1) IN154926B (da)
IT (1) IT1209373B (da)
LU (1) LU82950A1 (da)
NL (1) NL182565C (da)
NO (1) NO803521L (da)
NZ (1) NZ195596A (da)
PH (1) PH16666A (da)
PL (1) PL132354B1 (da)
PT (1) PT72090B (da)
SE (1) SE448732B (da)
SU (1) SU1042620A3 (da)
YU (1) YU41953B (da)
ZA (1) ZA807293B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
ATA570780A (de) 1985-12-15
CS782080A2 (en) 1985-06-13
NL8006362A (nl) 1981-06-16
HU179091B (en) 1982-08-28
ZA807293B (en) 1981-12-30
IN154926B (da) 1984-12-22
NL182565B (nl) 1987-11-02
FR2470132A1 (fr) 1981-05-29
IL61535A0 (en) 1980-12-31
IE50404B1 (en) 1986-04-16
CS241476B2 (en) 1986-03-13
DK151811B (da) 1988-01-04
GB2063862B (en) 1983-06-22
DE3043979C2 (de) 1986-08-21
NO803521L (no) 1981-05-25
IE802418L (en) 1981-05-23
ES497066A0 (es) 1982-04-01
KR830004322A (ko) 1983-07-09
PH16666A (en) 1983-12-13
DK413180A (da) 1981-05-24
JPS617432B2 (da) 1986-03-06
YU295080A (en) 1983-06-30
SE448732B (sv) 1987-03-16
AU6459580A (en) 1981-05-28
CH649299A5 (fr) 1985-05-15
PT72090B (en) 1981-09-29
AR228859A1 (es) 1983-04-29
PT72090A (en) 1980-12-01
FR2470132B1 (da) 1983-07-29
IT1209373B (it) 1989-07-16
FI67706C (fi) 1985-05-10
FI803628L (fi) 1981-05-24
PL132354B1 (en) 1985-02-28
LU82950A1 (fr) 1981-06-04
NZ195596A (en) 1984-05-31
BE886319A (fr) 1981-05-25
GB2063862A (en) 1981-06-10
DE3050491C2 (de) 1985-10-10
SU1042620A3 (ru) 1983-09-15
SE8008189L (sv) 1981-05-24
ES8203363A1 (es) 1982-04-01
EG14929A (en) 1989-01-30
PL228008A1 (da) 1981-12-11
IL61535A (en) 1984-06-29
DK151811C (da) 1988-06-06
GR72132B (da) 1983-09-19
IT8026176A0 (it) 1980-11-21
NL182565C (nl) 1988-04-05
AR231296A1 (es) 1984-10-31
AU520995B2 (en) 1982-03-11
GT198066458A (es) 1982-05-15
CA1143731A (en) 1983-03-29
JPS5687586A (en) 1981-07-16
DE3043979A1 (de) 1981-09-03
DD154608A5 (de) 1982-04-07
YU41953B (en) 1988-02-29
FI67706B (fi) 1985-01-31

Similar Documents

Publication Publication Date Title
AT366374B (de) Verfahren zur herstellung von neuen n3substituierten 5,5-dimethylhydantoinen
AT380259B (de) Verfahren zur herstellung von neuen peptidamiden
AT368509B (de) Verfahren zur herstellung von neuen 3-vinylcephalosporinen
AT367011B (de) Verfahren zur herstellung des neuen 1(s), 4(r),
ATA427680A (de) Verfahren zur herstellung von neuen 6-pyridazinonen
AT371816B (de) Verfahren zur herstellung von neuen isocyanurs[urederivaten
AT365588B (de) Verfahren zur herstellung von neuen spiropyridochroman-4',5-hydantoinen
AT380883B (de) Verfahren zur herstellung von neuen 1-oxo-1h -thiazolo(3,2-a)pyrimidin-2-carboxamiden
AT375941B (de) Verfahren zur herstellung von neuen 1-aminopyrazolo (1,5-c) chinazolinderivaten
AT380233B (de) Verfahren zur herstellung von neuen 1,7,7
AT373595B (de) Verfahren zur herstellung von neuen chinazolinen
AT368511B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT372947B (de) Verfahren zur herstellung von neuen trans-6oxodecahydrochinolinen
AT375653B (de) Verfahren zur herstellung von 2-oxodihydrobenzo(d)(1,3)-oxazinen
AT373872B (de) Verfahren zur herstellung von 2,2-dialkyl-4-methyl-5,5-dialkyl-3-formyl-3-pyr olinen
AT376437B (de) Verfahren zur herstellung von neuen pyrido(3,4-e)-as-triazin-derivaten
AT367758B (de) Verfahren zur herstellung von neuen 20-methyl-13, 14-didehydro-pgi 2-derivaten
ATA207781A (de) Verfahren zur herstellung von neuen 1,1,2-triphenyl-propen-derivaten
ATA216083A (de) Verfahren zur herstellung von neuen 1-nitropyrazolo(1,5-c)chinazolinderivaten
AT371114B (de) Verfahren zur herstellung von neuen phenyliminothiadiazolinen
AT371473B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT368163B (de) Verfahren zur herstellung von neuen 7alphamethoxycephalosporinen
AT368162B (de) Verfahren zur herstellung von neuen 7alphamethyoxycephalosporinen
ATA473881A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA573780A (de) Verfahren zur herstellung von neuen 5-aroyl-1,2dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carbons[ure

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee